These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? Machado CM; Leite NC; França PH; Cardoso CR; Salles GF; Villela-Nogueira CA Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):965-971. PubMed ID: 31377187 [TBL] [Abstract][Full Text] [Related]
24. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. Yasui K; Kawaguchi T; Shima T; Mitsuyoshi H; Seki K; Sendo R; Mizuno M; Itoh Y; Matsuda F; Okanoue T J Gastroenterol; 2015 Aug; 50(8):887-93. PubMed ID: 25543233 [TBL] [Abstract][Full Text] [Related]
25. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961 [TBL] [Abstract][Full Text] [Related]
26. PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels. Sun DQ; Zheng KI; Xu G; Ma HL; Zhang HY; Pan XY; Zhu PW; Wang XD; Targher G; Byrne CD; Chen YP; Yuan WJ; Zheng MH Liver Int; 2020 Jan; 40(1):107-119. PubMed ID: 31519069 [TBL] [Abstract][Full Text] [Related]
27. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients. Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study. Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X Gene; 2022 Apr; 820():146235. PubMed ID: 35143946 [TBL] [Abstract][Full Text] [Related]
30. Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD. Zhou YJ; Zheng KI; Ma HL; Li G; Pan XY; Zhu PW; Targher G; Byrne CD; Wang XD; Chen YP; Li XB; Zheng MH Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):552-560. PubMed ID: 33250371 [TBL] [Abstract][Full Text] [Related]
31. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population. Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251 [TBL] [Abstract][Full Text] [Related]
32. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. Targher G; Mantovani A; Alisi A; Mosca A; Panera N; Byrne CD; Nobili V Hepatology; 2019 Jul; 70(1):142-153. PubMed ID: 30912854 [TBL] [Abstract][Full Text] [Related]
33. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study. Uygun A; Ozturk K; Demirci H; Oztuna A; Eren F; Kozan S; Yilmaz Y; Kurt O; Turker T; Vatansever S; Alper E; Unsal B Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):441-447. PubMed ID: 28253210 [TBL] [Abstract][Full Text] [Related]
34. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans. Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455 [TBL] [Abstract][Full Text] [Related]
35. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449 [TBL] [Abstract][Full Text] [Related]
36. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study. Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A; J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992 [TBL] [Abstract][Full Text] [Related]
37. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368 [TBL] [Abstract][Full Text] [Related]
38. Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population. Wang S; Song J; Shang X; Chawla N; Yang Y; Meng X; Wang H; Ma J BMC Med Genet; 2016 Dec; 17(1):90. PubMed ID: 27905898 [TBL] [Abstract][Full Text] [Related]